InVivoMAb Anti-Human CD279/PDCD1/PD1 Antibody (TBS10312)

$489.00$2,399.00

Target: Programmed cell death protein 1, Protein PD-1, hPD-1, PD1, PDCD1, CD279.

SKU: TBS10312 Categories: ,
SKUStock SIZE (mg) PriceQuantity
TBS10312-0.5MG Yes 0.5 MG $489.00
spinner
TBS10312-1MG Yes 1 MG $719.00
spinner
TBS10312-5MG Yes 5 MG $2,399.00
spinner

Description

InVivoMAb Anti-Human Cluster of Differentiation 279 (CD279) antibody is a fully human monoclonal antibody targeting Programmed Cell Death Protein 1 (PD-1), isolated from the synthetic AMG phage display library. It binds a novel epitope on PD-1 and induces an unusual conformational change at the receptor’s N-terminus. Despite limited overlap with the natural ligand-binding site, CD279 effectively blocks PD-1 interaction with Programmed Death-Ligand 1 (PD-L1) and Programmed Death-Ligand 2 (PD-L2) through steric hindrance. The antibody shows high-affinity binding, recognizes PD-1 on activated human T cells, and cross-reacts with Cynomolgus monkey PD-1.

Synonyms: Anti‑PD‑1 antibody, anti‑CD279 antibody, Programmed Cell Death Protein 1 antibody, PDCD1 antibody.

Product Details

Applications: ELISA, Neutralization
Species reactivity: Human
Host: Mouse
Isotype: IgG2a
Target: Programmed cell death protein 1, Protein PD-1, hPD-1, PD1, PDCD1, CD279.
Uniprot: Q15116
Concentration: 3 mg/ml
Purity: >95%
Formulation: Liquid
Storage buffer: 0.01M PBS, pH 7.4
Purification: Protein A/G purified from cell culture supernatant.
Clonality: Monoclonal
Storage: Avoid repeated freeze-thaw cycles. Store at -20°C up to 12 months, -80°C long-term.

Data Image

 

Fig. 1. SDS-PAGE analysis of Anti-Human CD279 antibody

MW: Molecular Weight (kDa) Marker

R: Reducing conditions

NR: Non-Reducing conditions

Research use only.

Additional information

SIZE (mg)

1 MG, 5 MG, 0.5 MG

Reviews

There are no reviews yet.


Be the first to review “InVivoMAb Anti-Human CD279/PDCD1/PD1 Antibody (TBS10312)”